Qixiang Gui

Qixiang Gui

Auto-generated profile, based on publicly available information

Qixiang Gui

Department of Plastic and Reconstructive Surgery, Second Affiliated Hospital of Naval Medical University (Shanghai Changzheng Hospital), Shanghai 200003, China

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 December 2024 in Advanced Biology
Verified
Journal Article
Closed access
QGQixiang Gui
Qixiang Gui
NDNeng Ding
Neng Ding
HWHaimei Wu
Haimei Wu
JLJinyue Liu
Jinyue Liu
YGYingnan Geng
Yingnan Geng
LZLie Zhu
Lie Zhu

29 May 2025 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
QGQixiang Gui
Qixiang Gui
WLWenrong Luo
Wenrong Luo
DWDan Wu
Dan Wu
JLJinyue Liu
Jinyue Liu
DZDi Zhou
Di Zhou
LZLie Zhu
Lie Zhu

1 January 2025 in Stem Cells International
Verified
Journal Article
Open access
QGQixiang Gui
Qixiang Gui
NDNeng Ding
Neng Ding
JLJinyue Liu
Jinyue Liu
YZYunpeng Zhao
Yunpeng Zhao
ADAntong Du
Antong Du
LZLie Zhu
Lie Zhu
Ultraviolet (UV) radiation induces skin damage primarily through oxidative stress and excessive inflammation. Exosomes derived from mesenchymal stem cells have emerged as promising therapeutic agents for tissue repair. Here, we investigated the protective effects of human umbilical cord mesenchymal stem cell‐derived exosomes (HuMSC‐Exos) on UVB‐induced skin injury in HaCaTs and C57BL/6 mice. HuMSC‐Exos significantly reduced reactive oxygen species (ROS) levels, suppressed proinflammatory cytokines (IL‐1β, TNF‐α, and IL‐6), and improved cell migration. Mechanistically, HuMSC‐Exos inhibited Keap1, enhanced both total and phosphorylated Nrf2 expression, promoted its nuclear translocation, and upregulated antioxidant genes ( HMOX1 , NQO1 , CAT , and SOD2 ). miR‐200a‐3p in HuMSC‐Exos mediated these effects by targeting Keap1. Furthermore, preliminary data suggested that HuMSC‐Exos also attenuate inflammatory responses via the NF‐κB pathway. In vivo, HuMSC‐Exos attenuated UVB‐induced skin injury and inflammation by activating the Nrf2 signaling cascade. Collectively, our findings reveal a novel protective mechanism and highlight the therapeutic potential of HuMSC‐Exos in mitigating UV‐induced skin damage by modulating oxidative stress and inflammation.

29 May 2026 in Advanced Science
Verified
Journal Article
Open access
JGJiahao Guo
Jiahao Guo
YMYuanyuan Meng
Yuanyuan Meng
QGQixiang Gui
Qixiang Gui
XYXi‐Tao Yang
Xi‐Tao Yang
YFYong Fan
Yong Fan
XZXiaodong Zhu
Xiaodong Zhu
Diabetic wound healing is still a challenge, because the pathological microenvironment is characterized by a vicious cycle of oxidative stress, hypoxia, infection and chronic inflammation. Herein, we report a near‐infrared (NIR) light‐activated cascade nanodressing incorporated into a sprayable hyaluronic acid hydrogel. Under NIR irradiation, MXene serves not only as a photothermal substrate but also generates an interfacial electronic effect that drastically enhances the multienzyme‐mimicking activities of zinc hexacyanoferrate (ZnHCF), enabling efficient ROS clearance and alleviation of hypoxia. The mild photothermal effect further triggers‐controlled release of deferoxamine (DFO), which cooperates with ZnHCF to chelate free iron ions, thereby suppressing ROS generation at the source. The system also exhibits synergistic photothermal‐nanoknife‐Zn 2+ antibacterial efficacy, promoting macrophage repolarization from an M1 to an M2 phenotype. Moreover, DFO‐induced HIF‐1α upregulation facilitates angiogenesis and collagen deposition. Both in vitro and in vivo studies have confirmed that this sprayable nanodressing with “3A” (anti‐inflammatory, antibacterial, and angiogenic) effect can significantly accelerate the healing of diabetic wounds by improving the chronic wound microenvironment, achieving complete re‐epithelization within 13 days. This work sets the stage for a new generation of on‐demand, activated, synergistic systems, offering a viable path toward treating refractory tissue injuries.